Search Results - Sujie Ni

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study

    Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a coho... by Yongsheng Wang, Xi Wang, Jiong Wu, Hong Liu, Jiuda Zhao, Jian Huang, Jianxia Liu, Youling Gong, Hao Wang, Huaqing Yang, Guorong Zou, Quchang Ouyang, Guoqin Jiang, Huijuan Liu, Sujie Ni, Binghe Xu, Jinming Yu

    Published 2025-08-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: